103 related articles for article (PubMed ID: 29083862)
21. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
[TBL] [Abstract][Full Text] [Related]
22. Potential of amphiphilic graft copolymer α-tocopherol succinate-g-carboxymethyl chitosan in modulating the permeability and anticancer efficacy of tamoxifen.
Jena SK; Samal SK; Kaur S; Chand M; Sangamwar AT
Eur J Pharm Sci; 2017 Apr; 101():149-159. PubMed ID: 28214545
[TBL] [Abstract][Full Text] [Related]
23. Single-walled carbon nanotubes mediated targeted tamoxifen delivery system using aspargine-glycine-arginine peptide.
Chen C; Hou L; Zhang H; Zhu L; Zhang H; Zhang C; Shi J; Wang L; Jia X; Zhang Z
J Drug Target; 2013 Nov; 21(9):809-21. PubMed ID: 24024582
[TBL] [Abstract][Full Text] [Related]
24. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
[TBL] [Abstract][Full Text] [Related]
25. Extrahepatic deposition and cytotoxicity of lithocholic acid: studies in two hamster models of hepatic failure and in cultured human fibroblasts.
Ceryak S; Bouscarel B; Malavolti M; Fromm H
Hepatology; 1998 Feb; 27(2):546-56. PubMed ID: 9462656
[TBL] [Abstract][Full Text] [Related]
26. COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro.
Du Y; Shi A; Han B; Li S; Wu D; Jia H; Zheng C; Ren L; Fan Z
Int J Oncol; 2014 Apr; 44(4):1385-93. PubMed ID: 24535190
[TBL] [Abstract][Full Text] [Related]
27. Improve bile duct-targeted drug delivery and therapeutic efficacy for cholangiocarcinoma by cucurbitacin B loaded phospholipid complex modified with berberine hydrochloride.
Cheng L; Xu PH; Shen BD; Shen G; Li JJ; Qiu L; Liu CY; Yuan HL; Han J
Int J Pharm; 2015 Jul; 489(1-2):148-57. PubMed ID: 25882012
[TBL] [Abstract][Full Text] [Related]
28. Topotecan-tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential.
Khuroo T; Verma D; Talegaonkar S; Padhi S; Panda AK; Iqbal Z
Int J Pharm; 2014 Oct; 473(1-2):384-94. PubMed ID: 25051112
[TBL] [Abstract][Full Text] [Related]
29. Development of quercetin-phospholipid complex to improve the bioavailability and protection effects against carbon tetrachloride-induced hepatotoxicity in SD rats.
Zhang K; Zhang M; Liu Z; Zhang Y; Gu L; Hu G; Chen X; Jia J
Fitoterapia; 2016 Sep; 113():102-9. PubMed ID: 27431774
[TBL] [Abstract][Full Text] [Related]
30. Modulatory effects of L-carnitine on tamoxifen toxicity and oncolytic activity: in vivo study.
Ibrahim AB; Mansour HH; Shouman SA; Eissa AA; Abu El Nour SM
Hum Exp Toxicol; 2014 Sep; 33(9):968-79. PubMed ID: 24347302
[TBL] [Abstract][Full Text] [Related]
31. [Arsenic trioxide restores ERα expression in ERα-negative human breast cancer cells and its treatment efficacy in combination with tamoxifen in xenografts in nude mice].
Zhang WJ; Xu DF; Fan QX; Wu XA; Wang F; Wang R; Wang LX
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):645-51. PubMed ID: 23159075
[TBL] [Abstract][Full Text] [Related]
32. Allicin enhances chemotherapeutic response and ameliorates tamoxifen-induced liver injury in experimental animals.
Suddek GM
Pharm Biol; 2014 Aug; 52(8):1009-14. PubMed ID: 24646302
[TBL] [Abstract][Full Text] [Related]
33. The aromatase inactivator 4-hydroxyandrostenedione (4-OH-A) inhibits tamoxifen metabolism by rat hepatic cytochrome P-450 3A: potential for drug-drug interaction of tamoxifen and 4-OH-A in combined anti-breast cancer therapy.
Dehal SS; Brodie AM; Kupfer D
Drug Metab Dispos; 1999 Mar; 27(3):389-94. PubMed ID: 10064571
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, biodistribution, and estrogen receptor scintigraphy of indium-111-diethylenetriaminepentaacetic acid-tamoxifen analogue.
Delpassand ES; Yang DJ; Wallace S; Cherif A; Quadri SM; Price J; Joubert A; Inoue T; Podoloff DA
J Pharm Sci; 1996 Jun; 85(6):553-9. PubMed ID: 8773948
[TBL] [Abstract][Full Text] [Related]
35. Folic acid-conjugated amphiphilic alternating copolymer as a new active tumor targeting drug delivery platform.
Li X; Szewczuk MR; Malardier-Jugroot C
Drug Des Devel Ther; 2016; 10():4101-4110. PubMed ID: 28008233
[TBL] [Abstract][Full Text] [Related]
36. Development of tamoxifen-phospholipid complex: novel approach for improving solubility and bioavailability.
Jena SK; Singh C; Dora CP; Suresh S
Int J Pharm; 2014 Oct; 473(1-2):1-9. PubMed ID: 24992316
[TBL] [Abstract][Full Text] [Related]
37. Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery.
Thambi T; You DG; Han HS; Deepagan VG; Jeon SM; Suh YD; Choi KY; Kim K; Kwon IC; Yi GR; Lee JY; Lee DS; Park JH
Adv Healthc Mater; 2014 Nov; 3(11):1829-38. PubMed ID: 24753360
[TBL] [Abstract][Full Text] [Related]
38. ME3738 protects against lithocholic acid-induced hepatotoxicity, which is associated with enhancement of biliary bile acid and cholesterol output.
Nomoto M; Miyata M; Shimada M; Yoshinari K; Gonzalez FJ; Shibasaki S; Kurosawa T; Shindo Y; Yamazoe Y
Eur J Pharmacol; 2007 Nov; 574(2-3):192-200. PubMed ID: 17651726
[TBL] [Abstract][Full Text] [Related]
39. Dual drug delivery of tamoxifen and quercetin: Regulated metabolism for anticancer treatment with nanosponges.
Lockhart JN; Stevens DM; Beezer DB; Kravitz A; Harth E
J Control Release; 2015 Dec; 220(Pt B):751-7. PubMed ID: 26344396
[TBL] [Abstract][Full Text] [Related]
40. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
